Klein Integrative Physical Therapy | |
1712 I St Nw Ste 305, Washington, DC 20006-3766 | |
(202) 669-8098 | |
(202) 525-1249 |
Full Name | Klein Integrative Physical Therapy |
---|---|
Type | Facility |
Speciality | Physical Therapist |
Location | 1712 I St Nw Ste 305, Washington, District Of Columbia |
Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255656575 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | (* (Not Available)) | Primary |
Provider Name | Kate E Halon |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1891862876 PECOS PAC ID: 2567423734 Enrollment ID: I20041021000049 |
News Archive
For nearly two years, University of Michigan neurologist Eva Feldman , M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig 's disease.
Although endocrine therapy for breast cancer has shown excellent results in controlling the disease, responsiveness to the therapy depends on whether or not there is expression of estrogen receptors in breast cancer cells. Research from the Sbarro Institute for Cancer Research and Molecular Medicine, a nonprofit cancer, cardiovascular and diabetes research center located in Philadelphia, PA, reports on the effectiveness of a new molecule, Scriptaid, that restores receptivity to endocrine therapy in breast cancer cell lines that had tested negative for the expression of estrogen receptors.
Surgeons are making progress toward preventing initial and recurrent episodes of clostridium difficile colitis (C. difficile or C. diff), a vicious bacterial infection that is estimated to affect about 336,000 people each year, typically patients on antibiotics.
British scientists say a simple bowel cancer test could save thousands of lives by spotting the deadliest tumours.
› Verified 9 days ago
Provider Name | Lisa R Klein |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1164520482 PECOS PAC ID: 6406806371 Enrollment ID: I20050127001058 |
News Archive
For nearly two years, University of Michigan neurologist Eva Feldman , M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig 's disease.
Although endocrine therapy for breast cancer has shown excellent results in controlling the disease, responsiveness to the therapy depends on whether or not there is expression of estrogen receptors in breast cancer cells. Research from the Sbarro Institute for Cancer Research and Molecular Medicine, a nonprofit cancer, cardiovascular and diabetes research center located in Philadelphia, PA, reports on the effectiveness of a new molecule, Scriptaid, that restores receptivity to endocrine therapy in breast cancer cell lines that had tested negative for the expression of estrogen receptors.
Surgeons are making progress toward preventing initial and recurrent episodes of clostridium difficile colitis (C. difficile or C. diff), a vicious bacterial infection that is estimated to affect about 336,000 people each year, typically patients on antibiotics.
British scientists say a simple bowel cancer test could save thousands of lives by spotting the deadliest tumours.
› Verified 9 days ago
Provider Name | William E Amos |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1598951956 PECOS PAC ID: 5698941151 Enrollment ID: I20120104000669 |
News Archive
For nearly two years, University of Michigan neurologist Eva Feldman , M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig 's disease.
Although endocrine therapy for breast cancer has shown excellent results in controlling the disease, responsiveness to the therapy depends on whether or not there is expression of estrogen receptors in breast cancer cells. Research from the Sbarro Institute for Cancer Research and Molecular Medicine, a nonprofit cancer, cardiovascular and diabetes research center located in Philadelphia, PA, reports on the effectiveness of a new molecule, Scriptaid, that restores receptivity to endocrine therapy in breast cancer cell lines that had tested negative for the expression of estrogen receptors.
Surgeons are making progress toward preventing initial and recurrent episodes of clostridium difficile colitis (C. difficile or C. diff), a vicious bacterial infection that is estimated to affect about 336,000 people each year, typically patients on antibiotics.
British scientists say a simple bowel cancer test could save thousands of lives by spotting the deadliest tumours.
› Verified 9 days ago
Provider Name | Angela Em Venerable-joyner |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1083995070 PECOS PAC ID: 9335306539 Enrollment ID: I20120131000038 |
News Archive
For nearly two years, University of Michigan neurologist Eva Feldman , M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig 's disease.
Although endocrine therapy for breast cancer has shown excellent results in controlling the disease, responsiveness to the therapy depends on whether or not there is expression of estrogen receptors in breast cancer cells. Research from the Sbarro Institute for Cancer Research and Molecular Medicine, a nonprofit cancer, cardiovascular and diabetes research center located in Philadelphia, PA, reports on the effectiveness of a new molecule, Scriptaid, that restores receptivity to endocrine therapy in breast cancer cell lines that had tested negative for the expression of estrogen receptors.
Surgeons are making progress toward preventing initial and recurrent episodes of clostridium difficile colitis (C. difficile or C. diff), a vicious bacterial infection that is estimated to affect about 336,000 people each year, typically patients on antibiotics.
British scientists say a simple bowel cancer test could save thousands of lives by spotting the deadliest tumours.
› Verified 9 days ago
Provider Name | Zoe C Randol |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1902297211 PECOS PAC ID: 0446561450 Enrollment ID: I20150617002183 |
News Archive
For nearly two years, University of Michigan neurologist Eva Feldman , M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig 's disease.
Although endocrine therapy for breast cancer has shown excellent results in controlling the disease, responsiveness to the therapy depends on whether or not there is expression of estrogen receptors in breast cancer cells. Research from the Sbarro Institute for Cancer Research and Molecular Medicine, a nonprofit cancer, cardiovascular and diabetes research center located in Philadelphia, PA, reports on the effectiveness of a new molecule, Scriptaid, that restores receptivity to endocrine therapy in breast cancer cell lines that had tested negative for the expression of estrogen receptors.
Surgeons are making progress toward preventing initial and recurrent episodes of clostridium difficile colitis (C. difficile or C. diff), a vicious bacterial infection that is estimated to affect about 336,000 people each year, typically patients on antibiotics.
British scientists say a simple bowel cancer test could save thousands of lives by spotting the deadliest tumours.
› Verified 9 days ago
Provider Name | Udim S Isang |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1841650660 PECOS PAC ID: 3072891175 Enrollment ID: I20161025000241 |
News Archive
For nearly two years, University of Michigan neurologist Eva Feldman , M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig 's disease.
Although endocrine therapy for breast cancer has shown excellent results in controlling the disease, responsiveness to the therapy depends on whether or not there is expression of estrogen receptors in breast cancer cells. Research from the Sbarro Institute for Cancer Research and Molecular Medicine, a nonprofit cancer, cardiovascular and diabetes research center located in Philadelphia, PA, reports on the effectiveness of a new molecule, Scriptaid, that restores receptivity to endocrine therapy in breast cancer cell lines that had tested negative for the expression of estrogen receptors.
Surgeons are making progress toward preventing initial and recurrent episodes of clostridium difficile colitis (C. difficile or C. diff), a vicious bacterial infection that is estimated to affect about 336,000 people each year, typically patients on antibiotics.
British scientists say a simple bowel cancer test could save thousands of lives by spotting the deadliest tumours.
› Verified 9 days ago
Provider Name | Anne F Suazo |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1689708661 PECOS PAC ID: 5698036630 Enrollment ID: I20180307002442 |
News Archive
For nearly two years, University of Michigan neurologist Eva Feldman , M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig 's disease.
Although endocrine therapy for breast cancer has shown excellent results in controlling the disease, responsiveness to the therapy depends on whether or not there is expression of estrogen receptors in breast cancer cells. Research from the Sbarro Institute for Cancer Research and Molecular Medicine, a nonprofit cancer, cardiovascular and diabetes research center located in Philadelphia, PA, reports on the effectiveness of a new molecule, Scriptaid, that restores receptivity to endocrine therapy in breast cancer cell lines that had tested negative for the expression of estrogen receptors.
Surgeons are making progress toward preventing initial and recurrent episodes of clostridium difficile colitis (C. difficile or C. diff), a vicious bacterial infection that is estimated to affect about 336,000 people each year, typically patients on antibiotics.
British scientists say a simple bowel cancer test could save thousands of lives by spotting the deadliest tumours.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Klein Integrative Physical Therapy 1712 I St Nw Ste 305, Washington, DC 20006-3766 Ph: (202) 669-8098 | Klein Integrative Physical Therapy 1712 I St Nw Ste 305, Washington, DC 20006-3766 Ph: (202) 669-8098 |
News Archive
For nearly two years, University of Michigan neurologist Eva Feldman , M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig 's disease.
Although endocrine therapy for breast cancer has shown excellent results in controlling the disease, responsiveness to the therapy depends on whether or not there is expression of estrogen receptors in breast cancer cells. Research from the Sbarro Institute for Cancer Research and Molecular Medicine, a nonprofit cancer, cardiovascular and diabetes research center located in Philadelphia, PA, reports on the effectiveness of a new molecule, Scriptaid, that restores receptivity to endocrine therapy in breast cancer cell lines that had tested negative for the expression of estrogen receptors.
Surgeons are making progress toward preventing initial and recurrent episodes of clostridium difficile colitis (C. difficile or C. diff), a vicious bacterial infection that is estimated to affect about 336,000 people each year, typically patients on antibiotics.
British scientists say a simple bowel cancer test could save thousands of lives by spotting the deadliest tumours.
› Verified 9 days ago
Jeffrey Adam Miller, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1001 G St Nw, Washington, DC 20001 Phone: 202-347-7745 Fax: 202-347-7747 | |
Tyler Allee, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1705 Desales St Nw, 6th Floor, Washington, DC 20036 Phone: 202-630-0378 | |
Bettie R Kruger, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 Pennsylvania Ave Se, Suite 202, Washington, DC 20003 Phone: 202-543-9400 | |
Erin Foley, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1400 Defense St Pentagon, Washington, DC 20310 Phone: 037-692-8982 | |
Triumph Pediatric Center Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4900 Massachusetts Ave Nw # 340, Washington, DC 20016 Phone: 240-336-4976 | |
Vuong Duc Tran, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2021 K St Nw Ste 215, Washington, DC 20006 Phone: 240-898-4446 | |
Mr. Courtland Wyatt, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3700 N Capitol St Nw, Washington, DC 20011 Phone: 800-422-9988 Fax: 301-262-1259 |